Replimune Group(DE:7R8)
€19.51-0.42 (-2.11%)
DE:7R8
Replimune Group financials statements
€19.51
At close:-0.42 (-2.11%)
Replimune Group (7R8) Ratios
0 Followers
Replimune Group Ratios
DE:7R8's free cash flow for Q2 2027 was $-47.78M. For the 2027 fiscal year, DE:7R8's free cash flow was decreased by $-77.00K and operating cash flow was $-47.70M. See a summary of the company’s cash flow.
| Ratios | Mar 26 | Mar 25 | Mar 24 | Mar 23 | Mar 22 |
|---|---|---|---|---|---|
| Liquidity Ratios | |||||
| Current Ratio | 4.79 | 7.95 | 10.72 | 17.52 | 19.46 |
| Quick Ratio | 4.79 | 7.95 | 10.72 | 17.52 | 19.46 |
| Cash Ratio | 3.59 | 1.78 | 1.84 | 4.33 | 5.10 |
| Solvency Ratio | -1.87 | -1.78 | -1.86 | -1.88 | -2.27 |
| Operating Cash Flow Ratio | -4.81 | -3.08 | -4.59 | -3.79 | -3.96 |
| Short-Term Operating Cash Flow Coverage | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Net Current Asset Value | $ 112.89M | $ 360.39M | $ 320.45M | $ 501.30M | $ 354.01M |
| Leverage Ratios | |||||
| Debt-to-Assets Ratio | 0.34 | 0.14 | 0.16 | 0.09 | 0.07 |
| Debt-to-Equity Ratio | 0.67 | 0.18 | 0.20 | 0.11 | 0.08 |
| Debt-to-Capital Ratio | 0.40 | 0.15 | 0.17 | 0.10 | 0.07 |
| Long-Term Debt-to-Capital Ratio | 0.33 | 0.10 | 0.11 | 0.05 | 0.00 |
| Financial Leverage Ratio | 2.00 | 1.33 | 1.30 | 1.16 | 1.12 |
| Debt Service Coverage Ratio | -34.06 | -32.23 | -34.26 | -41.35 | -50.04 |
| Interest Coverage Ratio | -36.11 | -33.15 | -35.25 | -42.57 | -54.65 |
| Debt to Market Cap | 0.12 | 0.06 | 0.09 | 0.03 | 0.00 |
| Interest Debt Per Share | 1.30 | 1.04 | 1.24 | 1.12 | 0.67 |
| Net Debt to EBITDA | 0.32 | 0.14 | -0.01 | 0.50 | 0.64 |
| Profitability Margins | |||||
| Gross Profit Margin | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| EBIT Margin | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| EBITDA Margin | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Operating Profit Margin | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Pretax Profit Margin | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Net Profit Margin | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Continuous Operations Profit Margin | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Net Income Per EBT | 99.82% | 100.19% | 100.19% | 100.17% | 97.38% |
| EBT Per EBIT | 98.30% | 94.34% | 91.74% | 98.26% | 99.77% |
| Return on Assets (ROA) | -94.45% | -44.85% | -44.25% | -26.95% | -25.59% |
| Return on Equity (ROE) | -188.94% | -59.47% | -57.62% | -31.39% | -28.70% |
| Return on Capital Employed (ROCE) | -116.69% | -53.51% | -52.49% | -28.90% | -27.58% |
| Return on Invested Capital (ROIC) | -114.79% | -53.07% | -52.04% | -28.72% | -26.64% |
| Return on Tangible Assets | -94.45% | -44.85% | -44.25% | -26.95% | -25.59% |
| Earnings Yield | -44.22% | -31.48% | -41.94% | -16.95% | -13.31% |
| Efficiency Ratios | |||||
| Receivables Turnover | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Payables Turnover | 0.00 | 0.00 | 0.00 | 0.00 | 1.23 |
| Inventory Turnover | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Fixed Asset Turnover | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Asset Turnover | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Working Capital Turnover Ratio | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Cash Conversion Cycle | 0.00 | 0.00 | 0.00 | 0.00 | -297.74 |
| Days of Sales Outstanding | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Days of Inventory Outstanding | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Days of Payables Outstanding | 0.00 | 0.00 | 0.00 | 0.00 | 297.74 |
| Operating Cycle | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Cash Flow Ratios | |||||
| Operating Cash Flow Per Share | -3.02 | -2.39 | -2.79 | -2.20 | -1.57 |
| Free Cash Flow Per Share | -3.07 | -2.47 | -2.87 | -2.24 | -1.62 |
| Dividend Paid and CapEx Coverage Ratio | -66.39 | -28.75 | -32.76 | -56.41 | -35.18 |
| Capital Expenditure Coverage Ratio | -66.39 | -28.75 | -32.76 | -56.41 | -35.18 |
| Operating Cash Flow Coverage Ratio | -2.51 | -2.52 | -2.44 | -2.11 | -2.50 |
| Operating Cash Flow to Sales Ratio | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Free Cash Flow Yield | -40.08% | -25.33% | -37.14% | -12.68% | -9.53% |
| Valuation Ratios | |||||
| Price-to-Earnings (P/E) Ratio | -2.26 | -3.18 | -2.38 | -5.90 | -7.51 |
| Price-to-Sales (P/S) Ratio | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Price-to-Book (P/B) Ratio | 4.27 | 1.89 | 1.37 | 1.85 | 2.16 |
| Price-to-Free Cash Flow (P/FCF) Ratio | -2.49 | -3.95 | -2.69 | -7.89 | -10.49 |
| Price-to-Operating Cash Flow Ratio | -2.53 | -4.09 | -2.77 | -8.03 | -10.79 |
| Price-to-Earnings Growth (PEG) Ratio | -0.22 | 0.61 | -0.29 | -0.18 | -0.26 |
| Enterprise Value Multiple | -2.03 | -2.96 | -2.27 | -5.49 | -7.11 |
| Enterprise Value | 612.51M | 750.54M | 516.00M | 942.21M | 813.46M |
| EV to EBITDA | -2.03 | -2.96 | -2.27 | -5.49 | -7.11 |
| EV to Sales | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| EV to Free Cash Flow | -2.15 | -3.77 | -2.70 | -7.23 | -9.62 |
| EV to Operating Cash Flow | -2.18 | -3.90 | -2.78 | -7.36 | -9.90 |
| Tangible Book Value Per Share | 1.79 | 5.16 | 5.63 | 9.54 | 7.88 |
| Shareholders’ Equity Per Share | 1.79 | 5.16 | 5.63 | 9.54 | 7.88 |
| Tax and Other Ratios | |||||
| Effective Tax Rate | 0.00 | -0.00 | -0.00 | -0.00 | 0.03 |
| Revenue Per Share | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Net Income Per Share | -3.38 | -3.07 | -3.24 | -2.99 | -2.26 |
| Tax Burden | 1.00 | 1.00 | 1.00 | 1.00 | 0.97 |
| Interest Burden | 1.03 | 0.95 | 0.92 | 1.00 | 1.02 |
| Research & Development to Revenue | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| SG&A to Revenue | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Stock-Based Compensation to Revenue | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Income Quality | 0.89 | 0.78 | 0.86 | 0.73 | 0.70 |
Currency in USD

